When Precision Meets Production: AI in the CGT Manufacturing Lifecycle
From lab to life, the path of cell and gene therapies is filled with innovation—and complexity. As the demand grows, smarter, data-driven manufacturing becomes critical. Discover how AI and analytics are transforming CGT production by reducing errors, streamlining workflows, and making life-changing therapies more accessible.
Cell and gene therapies (CGTs) are among the most promising innovations in modern medicine. They hold the potential to treat and, in some cases, even cure conditions that were once considered untreatable. But while science is groundbreaking, the manufacturing side of things is often slow, expensive, and complex. Managing these will play an important part in ensuring that these complex but groundbreaking therapies are accessible to wider patient populations.
Know More About When Precision Meets Production: AI in the CGT Manufacturing Lifecycle : https://www.agilisium.com/blog....s/when-precision-mee
